0000313143-14-000024.txt : 20140210
0000313143-14-000024.hdr.sgml : 20140210
20140210134727
ACCESSION NUMBER: 0000313143-14-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140207
FILED AS OF DATE: 20140210
DATE AS OF CHANGE: 20140210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Jonathan
CENTRAL INDEX KEY: 0001457882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 14587651
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION INCORPORATED
STREET 2: 400 WOOD ROAD
CITY: BRAINTTREE
STATE: MA
ZIP: 02184
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-02-07
0
0000313143
HAEMONETICS CORP
HAE
0001457882
White Jonathan
400 WOOD ROAD
BRAINTREE
MA
02184
0
1
0
0
Chief Science and Technology
Common Stock
2014-02-07
4
S
0
700.0
38.66
D
26346
D
Common Stock
2014-02-07
4
S
0
315.0
38.672
D
26031
D
Common Stock
2014-02-07
4
S
0
865.0
38.66
D
25166
D
Non-Qualified Stock Option (right to buy)
26.47
2010-10-27
2016-10-27
Common Stock
24484
24484
D
Non-Qualified Stock Option (right to buy)
27.495
2011-10-27
2017-10-27
Common Stock
30776
30776
D
Non-Qualified Stock Option (right to buy)
30.025
2010-01-28
2016-01-28
Common Stock
35282
35282
D
Non-Qualified Stock Option (right to buy)
30.67
2012-10-25
2018-10-25
Common Stock
35130
35130
D
Non-Qualified Stock Option (right to buy)
33.925
2012-07-20
2018-07-20
Common Stock
27948
27948
D
Non-Qualified Stock Option (right to buy)
39.055
2013-10-24
2019-10-24
Common Stock
32192
32192
D
Non-Qualified Stock Option (right to buy)
41.66
2014-10-23
2019-10-23
Common Stock
28523
28523
D
Performance Shares
0.0
2017-03-31
2017-12-31
Common Stock
25000
25000
D
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
By: Alexander Steffan For: Jonathan White
2014-02-10